Ursolic Acid Enhances the Sensitivity of MCF-7 and MDA-MB-231 Cells to Epirubicin by Modulating the Autophagy Pathway
Breast cancer is the leading cause of cancer death among women in the world, and its morbidity and mortality are increasing year by year. Epirubicin (EPI) is a commonly used drug for the treatment of breast cancer but unfortunately can cause cardiac toxicity in patients because of dose accumulation....
Main Authors: | Zhennan Wang, Pingping Zhang, Huan Jiang, Bing Sun, Huaizhi Luo, Aiqun Jia |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-05-01
|
Series: | Molecules |
Subjects: | |
Online Access: | https://www.mdpi.com/1420-3049/27/11/3399 |
Similar Items
-
Initial Identification of UDP-Glucose Dehydrogenase as a Prognostic Marker in Breast Cancer Patients, Which Facilitates Epirubicin Resistance and Regulates Hyaluronan Synthesis in MDA-MB-231 Cells
by: Daiana L. Vitale, et al.
Published: (2021-02-01) -
Induction of Autophagy by Ursolic Acid Promotes the Elimination of Trypanosoma cruzi Amastigotes From Macrophages and Cardiac Cells
by: María Cristina Vanrell, et al.
Published: (2022-07-01) -
Preparation of a Highly Sensitive Electrochemical Aptasensor for Measuring Epirubicin Based on a Gold Electrode Boosted with Carbon Nano-Onions and MB
by: Esmail Sohouli, et al.
Published: (2022-12-01) -
A Hydrogel-Based Epirubicin Delivery System for Intravesical Chemotherapy
by: Ching-Wen Liu, et al.
Published: (2016-06-01) -
Polyphosphazene-Based Nanocarriers for the Release of Camptothecin and Epirubicin
by: Javier Pérez Quiñones, et al.
Published: (2022-01-01)